ENOVNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31

Enovis CORP

Financials through Q2 FY2026, quarter ended Jul 3, 2026Last filing: 10-Q on Aug 6, 2026

$19.87+0.28 (+1.43%)

Close on Oct 19, 2026

Market cap: $1.14B
P/E (TTM): –
Dividend yield: –

Enovis CORP cash flow statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31
Depreciation & Amortization	1,344	928	217	203	187	168	216	81	73	129	137	175	119	183	23	17	–
Stock-Based Compensation	33	30	34	39	35	29	22	25	22	19	16	18	13	9.37	4.91	3.14	2.59
Deferred Income Taxes	-2.23	-10	-27	24	-30	-52	-32	-57	-56	-8.91	-28	-139	9.95	7.22	-1.72	-0.30	2.69
Change in Accounts Receivable	-11	-57	-16	-45	-111	43	50	-72	-44	-51	64	-20	-99	-37	-5.97	-6.06	16
Change in Inventory	-12	39	-25	-119	-130	24	-45	-47	-34	20	-0.39	58	80	27	11	12	11
Change in Accounts Payable	-1.14	14	-6.64	-12	178	-31	-119	70	10	37	0.97	-26	129	89	-7.30	13	-21
Operating Cash Flow	217	114	135	-56	356	302	131	226	219	247	304	386	362	174	57	62	39
Capital Expenditures	-197	-181	-122	-105	-104	-115	-125	-70	-69	-63	-70	-84	-71	-84	-15	-13	-11
Acquisitions	-27	-770	-153	-74	-223	-70	-3,151	-291	-347	-26	-196	-949	-372	-1,860	-56	-28	-1.68
Sale of Property, Plant & Equipment	–	–	–	–	–	–	–	–	–	–	–	–	–	0.40	1.16	0.07	0.22
Divestitures	43	0	0	–	0	0	1,636	18	490	0	0	–	–	–	–	–	–
Sale & Maturity of Investments	–	–	–	–	–	0	0	139	0	0	–	–	–	–	–	–	–
Other Investing Activities	–	–	–	–	–	–	0	0	-6.13	0	19	3.12	0	1.86	0	–	–
Investing Cash Flow	-179	-955	-242	-176	-320	-175	-1,633	-168	90	-82	-247	-1,030	-475	-1,941	-70	-40	-12
Dividends Paid	–	–	–	–	–	–	–	–	–	–	–	–	–	0	0	-0.21	–
Share Repurchases	-3.50	-4.77	0	0	–	0	0	-200	0	-21	-27	0	0	–	–	–	–
Stock Issued	1.32	1.87	1.78	5.81	745	3.50	12	4.70	6.94	2.21	6.05	614	324	757	3.72	0.91	–
Debt Issued	–	–	–	–	–	–	–	–	–	0	750	150	51	1,732	0	0	–
Debt Repaid	–	–	–	–	0	-40	-1,388	-131	-66	-38	-1,233	-16	-680	-531	-10	-8.75	-5.00
Other Financing Activities	-6.62	-8.81	-3.54	-7.51	-9.87	-12	-12	-10	-10	-7.83	-21	-21	-25	-20	0	0	–
Financing Cash Flow	-52	847	128	-465	585	-132	1,369	-47	-280	-145	-131	650	-45	2,183	33	-8.04	-5.42
Foreign Exchange Rate Adjustments	2.70	-1.52	0.22	2.30	-2.23	-3.77	-3.07	-28	12	4.50	-34	-12	-13	-8.93	-5.36	-2.93	0.38
Net Change in Cash	-12	3.34	21	-695	618	-8.56	-135	-17	40	24	-108	-5.85	-171	407	15	11	21
Free Cash Flow	20	-67	13	-161	252	187	5.55	157	150	184	234	301	291	90	42	49	28
Income Taxes Paid	18	11	13	31	47	59	135	97	71	77	80	83	94	71	17	5.82	17
Interest Paid	27	52	16	37	85	105	139	50	43	36	36	42	59	80	5.21	6.11	6.62

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jul 3, 2026

Profitability, TTM

Gross margin: 61.1%
Operating margin: -45.1%
Net margin: -48.0%
Return on equity, FY2025: -58.5%

Financial strength

Current ratio: 1.98
Debt to equity: 0.87
Debt to assets: 34.1%
Cash to current liabilities: 2.1%

Valuation

P/E ratio: –
Price to sales: 0.50
Price to book: 0.77
Dividend yield: –